Compare SIBN & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIBN | GDRX |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 886.9M | 919.9M |
| IPO Year | 2018 | 2020 |
| Metric | SIBN | GDRX |
|---|---|---|
| Price | $17.48 | $2.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $25.57 | $4.80 |
| AVG Volume (30 Days) | 533.2K | ★ 2.1M |
| Earning Date | 02-23-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | $193,578,000.00 | ★ $800,651,000.00 |
| Revenue This Year | $21.44 | $2.35 |
| Revenue Next Year | $15.37 | $2.90 |
| P/E Ratio | ★ N/A | $33.07 |
| Revenue Growth | ★ 23.27 | 1.30 |
| 52 Week Low | $12.50 | $2.61 |
| 52 Week High | $21.89 | $5.81 |
| Indicator | SIBN | GDRX |
|---|---|---|
| Relative Strength Index (RSI) | 35.31 | 44.70 |
| Support Level | $17.01 | $2.73 |
| Resistance Level | $21.89 | $2.96 |
| Average True Range (ATR) | 0.91 | 0.10 |
| MACD | -0.39 | 0.02 |
| Stochastic Oscillator | 8.82 | 27.60 |
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.